These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2884131)

  • 1. Disruption of the Lys-290--Glu-342 salt bridge in human alpha 1-antitrypsin does not prevent its synthesis and secretion.
    Foreman RC
    FEBS Lett; 1987 May; 216(1):79-82. PubMed ID: 2884131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the 290-342 salt bridge is not responsible for the secretory defect of the PiZ alpha 1-antitrypsin variant.
    Sifers RN; Hardick CP; Woo SL
    J Biol Chem; 1989 Feb; 264(5):2997-3001. PubMed ID: 2563374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of amino acid substitutions at position 342 on the secretion of human alpha 1-antitrypsin from Xenopus oocytes.
    Wu Y; Foreman RC
    FEBS Lett; 1990 Jul; 268(1):21-3. PubMed ID: 2384157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repair of the secretion defect in the Z form of alpha 1-antitrypsin by addition of a second mutation.
    Brantly M; Courtney M; Crystal RG
    Science; 1988 Dec; 242(4886):1700-2. PubMed ID: 2904702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human alpha 1-antitrypsin expression in Xenopus oocytes. Secretion of the normal (PiM) and abnormal (PiZ) forms.
    Errington DM; Bathurst IC; Carrell RW
    Eur J Biochem; 1985 Dec; 153(2):361-5. PubMed ID: 3878282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenopus oocytes can synthesise but do not secrete the Z variant of human alpha 1-antitrypsin.
    Foreman RC; Judah JD; Colman A
    FEBS Lett; 1984 Mar; 168(1):84-8. PubMed ID: 6200362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 1-antitrypsin deficiency--a defect in secretion.
    Foreman RC
    Biosci Rep; 1987 Apr; 7(4):307-11. PubMed ID: 3499938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264----Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion.
    Curiel DT; Chytil A; Courtney M; Crystal RG
    J Biol Chem; 1989 Jun; 264(18):10477-86. PubMed ID: 2567291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342.
    McCracken AA; Kruse KB; Brown JL
    Mol Cell Biol; 1989 Apr; 9(4):1406-14. PubMed ID: 2786139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synthesis of M and Z forms of human alpha 1-antitrypsin.
    Errington DM; Bathurst IC; Janus ED; Carrell RW
    FEBS Lett; 1982 Nov; 148(1):83-6. PubMed ID: 6983458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Z alpha 1-antitrypsin accumulates intracellularly and stimulates lysosomal activity when synthesised in the Xenopus oocyte.
    Bathurst IC; Errington DM; Foreman RC; Judah JD; Carrell RW
    FEBS Lett; 1985 Apr; 183(2):304-8. PubMed ID: 3872810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants.
    Sidhar SK; Lomas DA; Carrell RW; Foreman RC
    J Biol Chem; 1995 Apr; 270(15):8393-6. PubMed ID: 7721731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mutations that alter the Glu264-Lys387 salt bridge on the secretion of alpha-1-proteinase inhibitor.
    Brodbeck RM; Samandari T; Brown JL
    J Biol Chem; 1993 Mar; 268(9):6771-6. PubMed ID: 8454649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation of plasma Z type alpha 1-antitrypsin suggests basic defect for the deficiency.
    Cox DW; Billingsley GD; Callahan JW
    FEBS Lett; 1986 Sep; 205(2):255-60. PubMed ID: 3488921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis, processing, and secretion of M and Z variant human alpha 1-antitrypsin.
    Verbanac KM; Heath EC
    J Biol Chem; 1986 Jul; 261(21):9979-89. PubMed ID: 3015914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting a surface cavity of alpha 1-antitrypsin to prevent conformational disease.
    Parfrey H; Mahadeva R; Ravenhill NA; Zhou A; Dafforn TR; Foreman RC; Lomas DA
    J Biol Chem; 2003 Aug; 278(35):33060-6. PubMed ID: 12807889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1-antitrypsin Wbethesda: molecular basis of an unusual alpha 1-antitrypsin deficiency variant.
    Holmes MD; Brantly ML; Fells GA; Crystal RG
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1013-20. PubMed ID: 2390072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin.
    Curiel D; Brantly M; Curiel E; Stier L; Crystal RG
    J Clin Invest; 1989 Apr; 83(4):1144-52. PubMed ID: 2539391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha 1-Antitrypsin Christchurch, 363 Glu----Lys: mutation at the P'5 position does not affect inhibitory activity.
    Brennan SO; Carrell RW
    Biochim Biophys Acta; 1986 Sep; 873(1):13-9. PubMed ID: 3527273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helix stabilization by Glu-...Lys+ salt bridges in short peptides of de novo design.
    Marqusee S; Baldwin RL
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):8898-902. PubMed ID: 3122208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.